国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產品名稱 貨號 規格
Recombinant Oryza sativa subsp. japonica Auxin response factor 25 (ARF25), partial CSB-YP651637OFG
CSB-EP651637OFG
CSB-BP651637OFG
CSB-MP651637OFG
CSB-EP651637OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica CBL-interacting protein kinase 4 (CIPK4) CSB-YP651638OFG
CSB-EP651638OFG
CSB-BP651638OFG
CSB-MP651638OFG
CSB-EP651638OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Cyclin-A3-2 (CYCA3-2) CSB-YP651639OFG
CSB-EP651639OFG
CSB-BP651639OFG
CSB-MP651639OFG
CSB-EP651639OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica RNA pseudourine synthase 1 (Os12g0560500, LOC_Os12g37380) CSB-YP651640OFG
CSB-EP651640OFG
CSB-BP651640OFG
CSB-MP651640OFG
CSB-EP651640OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Zinc finger CCCH domain-containing protein 67 (Os12g0515500, LOC_Os12g33090), partial CSB-YP651641OFG
CSB-EP651641OFG
CSB-BP651641OFG
CSB-MP651641OFG
CSB-EP651641OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Putative bifunctional dihydrofolate reductase-thymidylate synthase (Os12g0446900, LOC_Os12g26060) CSB-YP651642OFG
CSB-EP651642OFG
CSB-BP651642OFG
CSB-MP651642OFG
CSB-EP651642OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Zinc finger CCCH domain-containing protein 65 (Os12g0278800, LOC_Os12g18120), partial CSB-YP651643OFG
CSB-EP651643OFG
CSB-BP651643OFG
CSB-MP651643OFG
CSB-EP651643OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Putative protein Brevis radix-like 5 (BRXL5) CSB-YP651644OFG
CSB-EP651644OFG
CSB-BP651644OFG
CSB-MP651644OFG
CSB-EP651644OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Putative germin-like protein 12-4 (Os12g0155000, LOC_Os12g05880) CSB-YP651645OFG
CSB-EP651645OFG
CSB-BP651645OFG
CSB-MP651645OFG
CSB-EP651645OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Protein SCARECROW 2 (SCR2), partial CSB-YP651646OFG
CSB-EP651646OFG
CSB-BP651646OFG
CSB-MP651646OFG
CSB-EP651646OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Splicing factor U2af large subunit B (U2AF65B), partial CSB-YP651647OFG
CSB-EP651647OFG
CSB-BP651647OFG
CSB-MP651647OFG
CSB-EP651647OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Laccase-19 (LAC19), partial CSB-YP651648OFG
CSB-EP651648OFG
CSB-BP651648OFG
CSB-MP651648OFG
CSB-EP651648OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica CDK5RAP1-like protein (Os11g0592800, LOC_Os11g38030), partial CSB-YP651649OFG
CSB-EP651649OFG
CSB-BP651649OFG
CSB-MP651649OFG
CSB-EP651649OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica GDT1-like protein 2, chloroplastic (Os11g0544500, LOC_Os11g34180), partial CSB-YP651650OFG1
CSB-EP651650OFG1
CSB-BP651650OFG1
CSB-MP651650OFG1
CSB-EP651650OFG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Putative squamosa promoter-binding-like protein 19 (SPL19) CSB-YP651651OFG
CSB-EP651651OFG
CSB-BP651651OFG
CSB-MP651651OFG
CSB-EP651651OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica PHD finger protein ALFIN-LIKE 8 (Os11g0244800, LOC_Os11g14010) CSB-YP651652OFG
CSB-EP651652OFG
CSB-BP651652OFG
CSB-MP651652OFG
CSB-EP651652OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Cytochrome c-type biogenesis ccda-like chloroplastic protein 1 (CCDA1), partial CSB-YP651653OFG
CSB-EP651653OFG
CSB-BP651653OFG
CSB-MP651653OFG
CSB-EP651653OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Putative laccase-17 (LAC17), partial CSB-YP651654OFG
CSB-EP651654OFG
CSB-BP651654OFG
CSB-MP651654OFG
CSB-EP651654OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Influenza A virus Non-structural protein 1 (NS) CSB-YP651655IAAO
CSB-EP651655IAAO
CSB-BP651655IAAO
CSB-MP651655IAAO
CSB-EP651655IAAO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Influenza A virus Non-structural protein 1 (NS) CSB-YP651656IAAF
CSB-EP651656IAAF
CSB-BP651656IAAF
CSB-MP651656IAAF
CSB-EP651656IAAF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質形式,可以通過多種方式產生大量蛋白質、修改基因序列和制造有用的商業產品。重組蛋白的技術資源在重組蛋白的開發過程中,除了表達系統之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質量的重組蛋白,后續的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據他們開發重組蛋白的經驗總結出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產,在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質合成機制來產生由該基因編碼的蛋白質。表達載體可使外源基因在宿主細胞中高效表達,經過多年的發展,表達載體已成為一種成熟而受歡迎的生物技術。在重組蛋白生產過程中是一種基本成分。正如標題所示,本文主要總結了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質?

根據重組蛋白的不同應用,對其生物活性有不同的要求。但是我們如何確保蛋白質的產生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質有任何疑問,涉及到蛋白質的價格、交貨、質量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>